the clinical use of ctdna as a biomarker in tnbc
Published 6 months ago • 147 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
0:42
what future does ctdna have as a biomarker in breast cancer?
-
8:45
ctdna as a novel biomarker for mrd in crc
-
1:09
ctdna mrd as a biomarker for solid tumors
-
1:23
role of ctdna in mrd
-
2:36
imvigor010 & imvigor011: ctdna as a response biomarker for adjuvant atezolizumab in high-risk mibc
-
3:15
the potential of circulating cell-free dna as a breast cancer biomarker
-
1:26
potential role of ctdna for early-stage breast cancer
-
4:26
fundamentals of ctdna
-
6:22
utilising ctdna in oncology
-
0:45
the emerging role of ctdna in cancer diagnostics
-
0:58
real-world monitoring of circulating tumor dna to predict cancer recurrence
-
3:07
future uses of ctdna measurements: changing the treatment landscape
-
3:00
liquid biopsy: future directions for ctdna in nsclc
-
28:57
circulating tumor dna as an immunotherapy biomarker
-
3:05
the clinical use of circulating tumor dna in t-cell lymphomas
-
4:25
technical considerations for ctdna testing in nsclc
-
2:14
clinical and molecular characteristics of her2-low/zero early stage triple-negative breast cancer
-
1:07
clinical relevance of lipid biopsy and circulating tumor cells for precision medicine
-
1:36
ctdna assay for detection of recurrent disease in patients with early-stage breast cancer